These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31091594)

  • 61. Presentation, management, and outcome of newly diagnosed glioblastoma in elderly patients.
    Tanaka S; Meyer FB; Buckner JC; Uhm JH; Yan ES; Parney IF
    J Neurosurg; 2013 Apr; 118(4):786-98. PubMed ID: 23176331
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Algorithmic three-dimensional analysis of tumor shape in MRI improves prognosis of survival in glioblastoma: a multi-institutional study.
    Czarnek N; Clark K; Peters KB; Mazurowski MA
    J Neurooncol; 2017 Mar; 132(1):55-62. PubMed ID: 28074320
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinical analysis of the fatal cases of adult malignant gliomas after aggressive treatment].
    Takamura Y; Ibayashi Y; Morimoto S; Tanabe S; Hashi K
    No Shinkei Geka; 1994 Mar; 22(3):207-13. PubMed ID: 8133960
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
    Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
    Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
    An G; Ahn S; Park JS; Jeun SS; Hong YK
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
    Straube C; Kessel KA; Antoni S; Gempt J; Meyer B; Schlegel J; Schmidt-Graf F; Combs SE
    Radiat Oncol; 2020 May; 15(1):97. PubMed ID: 32375830
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reoperation for Recurrent Glioblastoma and Its Association With Survival Benefit.
    Tully PA; Gogos AJ; Love C; Liew D; Drummond KJ; Morokoff AP
    Neurosurgery; 2016 Nov; 79(5):678-689. PubMed ID: 27409404
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Impact of oligodendroglial component in glioblastoma (GBM-O): Is the outcome favourable than glioblastoma?
    Goda JS; Lewis S; Agarwal A; Epari S; Churi S; Padmavati A; Gupta T; Shetty P; Moiyadi A; Jalali R
    Clin Neurol Neurosurg; 2015 Aug; 135():46-53. PubMed ID: 26038275
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Survival outcomes of giant cell glioblastoma: institutional experience in the management of 20 patients.
    Oh T; Rutkowski MJ; Safaee M; Sun MZ; Sayegh ET; Bloch O; Tihan T; Parsa AT
    J Clin Neurosci; 2014 Dec; 21(12):2129-34. PubMed ID: 25037316
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
    Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
    Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.
    Sun MZ; Oh T; Ivan ME; Clark AJ; Safaee M; Sayegh ET; Kaur G; Parsa AT; Bloch O
    J Neurosurg; 2015 May; 122(5):1144-50. PubMed ID: 25768833
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
    Azoulay M; Santos F; Shenouda G; Petrecca K; Oweida A; Guiot MC; Owen S; Panet-Raymond V; Souhami L; Abdulkarim BS
    J Neurooncol; 2017 May; 132(3):419-426. PubMed ID: 28374095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
    Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
    World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The impact of surgery on the efficacy of adjuvant therapy in glioblastoma multiforme.
    Brzozowska A; ToruĊ„ A; Mazurkiewicz M
    Adv Clin Exp Med; 2015; 24(2):279-87. PubMed ID: 25931361
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pediatric supratentorial high-grade glioma: multicenter retrospective observational study of the Korean Society for Pediatric Neuro-Oncology.
    Jung TY; Lee JY; Kim DS; Park HJ; Kim CY; Ra YS; Lee MJ; Kim SH; Baek HJ; Kim IH; Park KD; Kim SK
    J Neurooncol; 2015 Jan; 121(2):413-9. PubMed ID: 25366367
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma.
    Wang SY; Ke YQ; Lu GH; Song ZH; Yu L; Xiao S; Sun XL; Jiang XD; Yang ZL; Hu CC
    J Neurooncol; 2013 May; 112(3):339-45. PubMed ID: 23417321
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
    Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J
    J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical characteristics of glioblastoma with metastatic spinal dissemination.
    Chen J; Shi Q; Li S; Zhao Y; Huang H
    Ann Palliat Med; 2022 Feb; 11(2):506-512. PubMed ID: 35249328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.